CombiMatrix

CombiMatrix Corp (NASDAQ: CBMX), a molecular diagnostics company, announced on Thursday it has begun to explore strategic alternatives, including potential M&A activity and business development opportunities. The company noted its strategic review process is intended to enhance shareholder...